Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 456407, 11 pages
http://dx.doi.org/10.1155/2013/456407
Research Article

The Subcellular Localization of the Receptor for Platelet-Activating Factor in Neutrophils Affects Signaling and Activation Characteristics

Department of Rheumatology and Inflammation Research, Göteborg University, Guldhedsgatan 10A, 413 46 Göteborg, Sweden

Received 26 April 2013; Accepted 22 July 2013

Academic Editor: Richard L. Gallo

Copyright © 2013 Emil Andréasson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. McDonald, K. Pittman, G. B. Menezes et al., “Intravascular danger signals guide neutrophils to sites of sterile inflammation,” Science, vol. 330, no. 6002, pp. 362–366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. G. B. Segel, M. W. Halterman, and M. A. Lichtman, “The paradox of the neutrophil's role in tissue injury,” Journal of Leukocyte Biology, vol. 89, no. 3, pp. 359–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. F. Miller and J. J. Falke, “Chemotaxis receptors and signaling,” Advances in Protein Chemistry, vol. 68, pp. 393–444, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. R. D. Ye, F. Boulay, M. W. Ji et al., “International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family,” Pharmacological Reviews, vol. 61, no. 2, pp. 119–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Stephens, L. Milne, and P. Hawkins, “Moving towards a better understanding of chemotaxis,” Current Biology, vol. 18, no. 11, pp. R485–R494, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. S. Powell and J. Rokach, “Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE,” Progress in Lipid Research, vol. 44, no. 2-3, pp. 154–183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. P. Wymann, S. Sozzani, F. Altruda, A. Mantovani, and E. Hirsch, “Lipids on the move: phosphoinositide 3-kinases in leukocyte function,” Immunology Today, vol. 21, no. 6, pp. 260–264, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. G. A. Zimmerman, T. M. McIntyre, S. M. Prescott, and D. M. Stafforini, “The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis,” Critical Care Medicine, vol. 30, supplement 5, pp. S294–S301, 2002. View at Google Scholar · View at Scopus
  9. S. M. Prescott, G. A. Zimmerman, D. M. Stafforini, and T. M. McIntyre, “Platelet-activating factor and related lipid mediators,” Annual Review of Biochemistry, vol. 69, pp. 419–445, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. R. D. Ye and F. Boulay, “Structure and function of leukocyte chemoattractant receptors,” Advances in Pharmacology C, vol. 39, pp. 221–289, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. D. J. Dupré, C. Thompson, Z. Chen et al., “Inverse agonist-induced signaling and down-regulation of the platelet-activating factor receptor,” Cellular Signalling, vol. 19, no. 10, pp. 2068–2079, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. M. McManus and R. N. Pinckard, “PAF, a putative mediator of oral inflammation,” Critical Reviews in Oral Biology and Medicine, vol. 11, no. 2, pp. 240–258, 2000. View at Google Scholar · View at Scopus
  13. E. J. Welch, R. P. Naikawadi, Z. Li et al., “Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation,” Molecular Pharmacology, vol. 75, no. 1, pp. 227–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. T. M. Osborn, C. Dahlgren, J. H. Hartwig, and T. P. Stossel, “Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin,” American Journal of Physiology, vol. 292, no. 4, pp. C1323–C1330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. F. R. Sheppard, M. R. Kelher, E. E. Moore, N. J. D. McLaughlin, A. Banerjee, and C. C. Silliman, “Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation,” Journal of Leukocyte Biology, vol. 78, no. 5, pp. 1025–1042, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Condliffe, E. Kitchen, and E. R. Chilvers, “Neutrophil priming: pathophysiological consequences and underlying mechanisms,” Clinical Science, vol. 94, no. 5, pp. 461–471, 1998. View at Google Scholar · View at Scopus
  17. J. Almkvist, J. Fäldt, C. Dahlgren, H. Leffler, and A. Karlsson, “Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe,” Infection and Immunity, vol. 69, no. 2, pp. 832–837, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Bylund, A. Karlsson, F. Boulay, and C. Dahlgren, “Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1,” Infection and Immunity, vol. 70, no. 6, pp. 2908–2914, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Almkvist, C. Dahlgren, H. Leffler, and A. Karlsson, “Newcastle disease virus neuraminidase primes neutrophils for stimulation by galectin-3 and formyl-Met-Leu-Phe,” Experimental Cell Research, vol. 298, no. 1, pp. 74–82, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Karlsson, P. Follin, H. Leffler, and C. Dahlgren, “Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils,” Blood, vol. 91, no. 9, pp. 3430–3438, 1998. View at Google Scholar · View at Scopus
  21. H. Fu, J. Bylund, A. Karlsson, S. Pellmé, and C. Dahlgren, “The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8,” Immunology, vol. 112, no. 2, pp. 201–210, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Faurschou and N. Borregaard, “Neutrophil granules and secretory vesicles in inflammation,” Microbes and Infection, vol. 5, no. 14, pp. 1317–1327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Boyum, D. Lovhaug, L. Tresland, and E. M. Nordlie, “Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality,” Scandinavian Journal of Immunology, vol. 34, no. 6, pp. 697–712, 1991. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Lundqvist and C. Dahlgren, “Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils,” Free Radical Biology and Medicine, vol. 20, no. 6, pp. 785–792, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Dahlgren and A. Karlsson, “Respiratory burst in human neutrophils,” Journal of Immunological Methods, vol. 232, no. 1-2, pp. 3–14, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Kjeldsen, H. Sengeløv, and N. Borregaard, “Subcellular fractionation of human neutrophils on Percoll density gradients,” Journal of Immunological Methods, vol. 232, no. 1-2, pp. 131–143, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Karlsson, J. Bylund, C. Movitz, L. Björkman, H. Forsman, and C. Dahlgren, “A methodological approach to studies of desensitization of the formyl peptide receptor: role of the read out system, reactive oxygen species and the specific agonist used to trigger neutrophils,” Journal of Immunological Methods, vol. 352, no. 1-2, pp. 45–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Andersson, C. Dahigren, P. D. Lew, and O. Stendahl, “Cell surface expression of fMet-Leu-Phe receptors on human neutrophils. Correlation to changes in the cytosolic free Ca2+ level and action of phorbol myristate acetate,” Journal of Clinical Investigation, vol. 79, no. 4, pp. 1226–1233, 1987. View at Google Scholar · View at Scopus
  29. H. Sengelov, F. Boulay, L. Kjeldsen, and N. Borregaard, “Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils,” Biochemical Journal, vol. 299, no. 2, pp. 473–479, 1994. View at Google Scholar · View at Scopus
  30. N. Borregaard, O. E. Sørensen, and K. Theilgaard-Mönch, “Neutrophil granules: a library of innate immunity proteins,” Trends in Immunology, vol. 28, no. 8, pp. 340–345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Dewald and M. Baggiolini, “Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4,” Biochemical and Biophysical Research Communications, vol. 128, no. 1, pp. 297–304, 1985. View at Google Scholar · View at Scopus
  32. I. Daniels, M. A. Lindsay, C. I. C. Keany, R. P. Burden, J. Fletcher, and A. P. Haynes, “Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluent,” Clinical and Diagnostic Laboratory Immunology, vol. 5, no. 5, pp. 683–689, 1998. View at Google Scholar · View at Scopus
  33. B. Dewald and M. Baggiolini, “Platelet-activating factor as a stimulus of exocytosis in human neutrophils,” Biochimica et Biophysica Acta, vol. 888, no. 1, pp. 42–48, 1986. View at Google Scholar · View at Scopus
  34. K. N. Klotz and A. J. Jesaitis, “Neutrophil chemoattractant receptors and the membrane skeleton,” BioEssays, vol. 16, no. 3, pp. 193–198, 1994. View at Google Scholar · View at Scopus
  35. L. Liu, O. Harbecke, H. Elwing, P. Follin, A. Karlsson, and C. Dahlgren, “Desensitization of formyl peptide receptors is abolished in calcium ionophore-primed neutrophils: an association of the ligand-receptor complex to the cytoskeleton is not required for a rapid termination of the NADPH- oxidase response,” Journal of Immunology, vol. 160, no. 5, pp. 2463–2468, 1998. View at Google Scholar · View at Scopus
  36. O. Harbecke, L. Liu, A. Karlsson, and C. Dahlgren, “Desensitization of the fMLP-induced NADPH-oxidase response in human neutrophils is lacking in okadaic acid-treated cells,” Journal of Leukocyte Biology, vol. 61, no. 6, pp. 753–758, 1997. View at Google Scholar · View at Scopus
  37. M. J. Berridge, “Inositol trisphosphate and calcium signalling,” Nature, vol. 361, no. 6410, pp. 315–325, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. G. M. Bokoch, “Chemoattractant signaling and leukocyte activation,” Blood, vol. 86, no. 5, pp. 1649–1660, 1995. View at Google Scholar · View at Scopus
  39. J. Karlsson, A. Stenfeldt, M. Rabiet, J. Bylund, H. F. Forsman, and C. Dahlgren, “The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels,” Cell Calcium, vol. 45, no. 5, pp. 431–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Andersson, C. Dahlgren, and T. Pozzan, “Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils,” Molecular Pharmacology, vol. 30, no. 5, pp. 437–443, 1986. View at Google Scholar · View at Scopus
  41. H. Fu, J. Karlsson, J. Bylund, C. Movitz, A. Karlsson, and C. Dahlgren, “Ligand recognition and activation of formyl peptide receptors in neutrophils,” Journal of Leukocyte Biology, vol. 79, no. 2, pp. 247–256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Heit, S. Tavener, E. Raharjo, and P. Kubes, “An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients,” Journal of Cell Biology, vol. 159, no. 1, pp. 91–102, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Forsman, K. Onnheim, E. Andréasson et al., “Reactivation of desensitized formyl peptide receptors by platelet activating factor: a novel receptor cross talk mechanism regulating neutrophil superoxide anion production,” PLoS One, vol. 8, Article ID e60169, 2013. View at Google Scholar
  44. K. Önnheim, J. Bylund, F. Boulay, C. Dahlgren, and H. Forsman, “Tumour necrosis factor (TNF)-α primes murine neutrophils when triggered via formyl peptide receptor-related sequence 2, the murine orthologue of human formyl peptide receptor-like 1, through a process involving the type I TNF receptor and subcellular granule mobilization,” Immunology, vol. 125, no. 4, pp. 591–600, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Elbim, S. Bailly, S. Chollet-Martin, J. Hakim, and M. A. Gougerot-Pocidalo, “Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides,” Infection and Immunity, vol. 62, no. 6, pp. 2195–2201, 1994. View at Google Scholar · View at Scopus
  46. J. El-Benna, P. M. Dang, and M. Gougerot-Pocidalo, “Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane,” Seminars in Immunopathology, vol. 30, no. 3, pp. 279–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. N. J. McLaughlin, A. Banerjee, S. Y. Khan et al., “Platelet-activating factor-mediated endosome formation causes membrane translocation of p67phox and p40phox that requires recruitment and activation of p38 MAPK, Rab5a, and phosphatidylinositol 3-kinase in human neutrophils,” Journal of Immunology, vol. 180, no. 12, pp. 8192–8203, 2008. View at Google Scholar · View at Scopus
  48. J. Bylund, Å. Björstad, D. Granfeldt, A. Karlsson, C. Woschnagg, and C. Dahlgren, “Reactivation of formyl peptide receptors triggers the neutrophil NADPH-oxidase but not a transient rise in intracellular calcium,” Journal of Biological Chemistry, vol. 278, no. 33, pp. 30578–30586, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Bylund, K. L. Brown, C. Movitz, C. Dahlgren, and A. Karlsson, “Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for?” Free Radical Biology and Medicine, vol. 49, no. 12, pp. 1834–1845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Dahlgren, A. Karlsson, and J. Bylund, “Measurement of respiratory burst products generated by professional phagocytes,” Methods in Molecular Biology, vol. 412, pp. 349–363, 2007. View at Google Scholar · View at Scopus
  51. W. Zhou and M. S. Olson, “A mechanism for phorbol ester-mediated regulation of the PAF receptor in human neutrophils,” Archives of Biochemistry and Biophysics, vol. 313, no. 1, pp. 179–183, 1994. View at Publisher · View at Google Scholar · View at Scopus
  52. D. J. Dupré, Z. Chen, C. Le Gouill et al., “Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor,” Journal of Biological Chemistry, vol. 278, no. 48, pp. 48228–48235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. J. A. Nick, N. J. Avdi, S. K. Young et al., “Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP,” Journal of Clinical Investigation, vol. 99, no. 5, pp. 975–986, 1997. View at Google Scholar · View at Scopus